ITGA2

(redirected from GPIA)
Also found in: Acronyms.

ITGA2

A gene on chromosome 5q11.2 that encodes an integrin alpha chain protein which, like all integrins, forms a heterodimer with a beta chain, thereby participating in an array of cell-cell and cell-matrix interactions, playing a major role in cell migration, organ and tissue development and differentiation. Alpha-2 beta-1 heterodimers serve as receptors for laminin, collagen, collagen C-propeptides, fibronectin and E-cadherin, and is responsible for adhesion of platelets and other cells to the extracellular matrix, modulation of collagen and collagenase gene expression and organisation of newly synthesised extracellular matrix.
Mentioned in ?
References in periodicals archive ?
En el analisis economico-ambiental de la variante CA, se contabilizo como gasto adicional por preservacion ambiental (GPIA), la adquisicion de recursos materiales para la construccion inicial de cuatro granjas de cultivo, con una produccion esperada de ~21.000 kg de ostion en concha, a partir de un total de 3.900 colectores de concha madre, ademas de 50 cajas ostricolas tipo Nestier[TM], con fines demostrativos.
The GPIA was created by the Paris Chamber of Commerce and Industry 15 years ago to highlight Greater Paris as the business capital of Europe.
Bill Haddad, one of the founders of the GPIA, which preceded the GPhA, believes that laws allowing generic versions of biological products will develop as a result of prescription drug coverage to the Medicare program.
In 1981 they formed the Generic Pharmaceutical Industry Association (GPIA) and immediately began to compile evidence against patent extension.
GPIa C807T, ACE I/D, and GPIIIa ([Pl.sup.A1]/[Pl.sup.A2]) T1565C were genotyped using PCR-based methods described previously (21, 24, 32).
Till served as vice president of scientific affairs at GPIA (now the Generic Pharmaceutical Association, or GPhA) from 1995 until mid-1997.
The GPIA and NPA boards also unanimously approved an overall governance and participatory structure, bylaws, dues structure and initial priorities for the new organization.
WASHINGTON -- The Generic Pharmaceutical Industry Association (GPIA) has outlined five principles that it believes will help legislators carve out an affordable drug benefit for senior citizens.
The invitation to take part in the Transatlantic Business Dialogue (TABD) comes as the result of a three-year campaign engineered by the Generic Pharmaceutical Industry Association (GPIA) on behalf of its members.
That's why the three leading trade groups: the Generic Pharmaceutical Industry Association (GPIA), the National Association of Pharmaceutical Manufacturers and the National Pharmaceutical Alliance have increasingly abandoned individual preferences in some areas to instead collaborate on initiatives that will benefit the industry as a whole.
Last year, for example, the Generic Pharmaceutical Industry Association (GPIA), the National Association of Pharmaceutical Manufacturers (NAPM) and the National Pharmaceutical Alliance (NPA) banded together as the Coalition for Affordable Pharmaceuticals, an organization that is dedicated to educating consumers about the benefits of generic medications.
"By opposing the pediatric exclusivity provision of FDAMA the generics industry appears to be against children," Mike Dey, vice chairman of the Generic Pharmaceutical Industry Association (GPIA), noted at that group's annual meeting in March.